Short Interest in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Grows By 17.9%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) saw a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 1,614,672 shares, a growth of 17.9% from the February 12th total of 1,369,172 shares. Based on an average daily volume of 5 shares, the days-to-cover ratio is currently 322,934.4 days. Based on an average daily volume of 5 shares, the days-to-cover ratio is currently 322,934.4 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

Shares of OTCMKTS:SFOSF opened at $2.44 on Tuesday. Shanghai Fosun Pharmaceutical has a 1-year low of $1.62 and a 1-year high of $3.50. The business has a fifty day moving average price of $2.64 and a 200-day moving average price of $2.99.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.